The Stem Cell Therapeutic and Research Act has provided funding

The Stem Cell Therapeutic and Research Act has provided funding

to expand public banking initiatives in the United States and to create a more ethnically diverse inventory of units. Private storage is not advocated unless there is an identified need in the family such that banked cord blood would offer a benefit. A recent report outlined the challenges of increasing participation and inventory, particularly among minority groups. Obstetricians and other health care practitioners should have a primary role in efforts to increase awareness of umbilical cord blood donation and be involved in initiatives to expand current public banking activities. (Obstet Gynecol 2013;121:851-5) DOI: http://10.1097/AOG.0b013e31828882aa”
“Objective.

To Momelotinib inhibitor assess the effects of preclinic group education sessions and system redesign on tertiary pain medicine units and patient outcomes.

Design.

Prospective

cohort study.

Setting.

Two public hospital multidisciplinary pain medicine units.

Patients.

People with persistent pain.

Interventions.

A system redesign from a “”traditional”" model (initial individual medical appointments) to a model that delivers group education sessions prior to individual appointments. Based on Patient Triage Questionnaires patients were scheduled to attend Self-Training Educative AZD8186 manufacturer Pain Sessions (STEPS), a two day eight hour group education program, followed by optional patient-initiated clinic appointments.

Outcome Measures.

Number of patients completing Selleck BTSA1 STEPS who subsequently requested individual outpatient clinic appointment(s); wait-times; unit cost per new patient referred; recurrent health care utilization; patient satisfaction; Global Perceived

Impression of Change (GPIC); and utilized pain management strategies.

Results.

Following STEPS 48% of attendees requested individual outpatient appointments. Wait times reduced from 105.6 to 16.1 weeks at one pain unit and 37.3 to 15.2 weeks at the second. Unit cost per new patient appointed reduced from $1,805 Australian Dollars (AUD) to AUD$541 (for STEPS). At 3 months, patients scored their satisfaction with “”the treatment received for their pain”" more positively than at baseline (change score = 0.88; P = 0.0003), GPIC improved (change score = 0.46; P < 0.0001) and mean number of active strategies utilized increased by 4.12 per patient (P = 0.0004).

Conclusions.

The introduction of STEPS was associated with reduced wait-times and costs at public pain medicine units and increased both the use of active pain management strategies and patient satisfaction.”
“Leiomyomas are the most common pelvic tumors in women. These tumors are not always symptomatic but can cause abnormal uterine bleeding and anemia, pelvic pressure and pain, urinary frequency, and adverse reproductive outcomes-symptoms that can diminish the quality of life of women.

Comments are closed.